BRUCE ERIC J

CIK 00013306911 companyBRISTOL, TN

SEC Profile

Transactions

Companies

Filings

CIK

0001330691

Recent Transactions

33 trades

Disposition to Issuer
KING PHARMACEUTICALS INC
Common Stock
2011-01-31−38,870→ 0 total
Other
KING PHARMACEUTICALS INC
Stock Option (Right to Buy)
2011-01-31−50,000→ 0 total
Disposition to Issuer
KING PHARMACEUTICALS INC
Performance Share Units
2011-01-31−17,758→ 0 total
Disposition to Issuer
KING PHARMACEUTICALS INC
Performance Share Units
2011-01-31−55,420→ 0 total
Disposition from Tender
KING PHARMACEUTICALS INC
Common Stock
2011-01-31−170,709→ 38,870 total
Other
KING PHARMACEUTICALS INC
Stock Option (Right to Buy)
2011-01-31−35,180→ 0 total
Other
KING PHARMACEUTICALS INC
Stock Option (Right to Buy)
2011-01-31−42,000→ 0 total
Award
KING PHARMACEUTICALS INC
Long-Term Performance Unit
2011-01-18+17,758→ 17,758 total
Award
KING PHARMACEUTICALS INC
Common Stock
2011-01-07+16,720→ 209,579 total
Award
KING PHARMACEUTICALS INC
Common Stock
2011-01-07+16,720→ 170,579 total
Exercise/Conversion
KING PHARMACEUTICALS INC
Common Stock
2010-12-31+39,000→ 209,579 total
Exercise/Conversion
KING PHARMACEUTICALS INC
Long-Term Performance Unit
2010-12-31−39,000→ 0 total
Tax Payment
KING PHARMACEUTICALS INC
Common Stock
2010-12-14$14.22/sh−26,244→ 153,859 total
Tax Payment
KING PHARMACEUTICALS INC
Common Stock
2010-03-22$12.25/sh−2,405→ 180,103 total
Award
KING PHARMACEUTICALS INC
Stock Option (Right to Buy)
2010-03-17+42,000→ 42,000 total
Award
KING PHARMACEUTICALS INC
Common Stock
2010-03-17+11,900→ 182,508 total
Tax Payment
KING PHARMACEUTICALS INC
Common Stock
2010-03-10$12.22/sh−5,587→ 170,608 total
Award
KING PHARMACEUTICALS INC
Long-Term Performance Unit
2010-02-25+55,420→ 55,420 total
Exercise/Conversion
KING PHARMACEUTICALS INC
Common Stock
2009-12-31+21,120→ 176,195 total
Exercise/Conversion
KING PHARMACEUTICALS INC
Long-Term Performance Unit
2009-12-31−21,120→ 0 total
Award
KING PHARMACEUTICALS INC
Common Stock
2009-03-23+15,830→ 155,075 total
Award
KING PHARMACEUTICALS INC
Stock Option (Right to Buy)
2009-03-23+50,000→ 50,000 total
Tax Payment
KING PHARMACEUTICALS INC
Common Stock
2009-03-20$6.80/sh−2,230→ 139,245 total
Tax Payment
KING PHARMACEUTICALS INC
Common Stock
2009-03-10$6.31/sh−6,583→ 141,475 total
Award
KING PHARMACEUTICALS INC
Long-Term Performance Unit
2009-02-17+39,000→ 39,000 total
Award
KING PHARMACEUTICALS INC
Common Stock
2009-01-16+3,823→ 148,058 total
Award
KING PHARMACEUTICALS INC
Common Stock
2009-01-16+3,823→ 148,058 total
Exercise/Conversion
KING PHARMACEUTICALS INC
Long-Term Performance Unit
2008-12-31−21,060→ 0 total
Exercise/Conversion
KING PHARMACEUTICALS INC
Common Stock
2008-12-31+21,060→ 144,235 total
Exercise/Conversion
KING PHARMACEUTICALS INC
Common Stock
2008-12-31+21,060→ 144,235 total
Exercise/Conversion
KING PHARMACEUTICALS INC
Long-Term Performance Unit
2008-12-31−21,060→ 0 total
Award
KING PHARMACEUTICALS INC
Common Stock
2007-03-21+9,090→ 48,132 total
Award
KING PHARMACEUTICALS INC
Stock Option (Right to Buy)
2007-03-21+17,880→ 17,880 total

Companies

KING PHARMACEUTICALS INC
President, Animal Health

Recent Filings

Address

501 FIFTH STREET

BRISTOL, TN, 37620

View on SEC.gov